{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T21:05:38Z","timestamp":1779138338322,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Early Human Development"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.earlhumdev.2011.12.012","type":"journal-article","created":{"date-parts":[[2012,4,22]],"date-time":"2012-04-22T08:15:38Z","timestamp":1335082538000},"page":"503-507","source":"Crossref","is-referenced-by-count":46,"title":["Neonatal side effects of maternal labetalol treatment in severe preeclampsia"],"prefix":"10.1016","volume":"88","author":[{"given":"Karst Y.","family":"Heida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerda G.","family":"Zeeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teelkien R.","family":"Van Veen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian V.","family":"Hulzebos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.earlhumdev.2011.12.012_bb0155","article-title":"Chesley's hypertensive disorders in pregnancy","year":"2009"},{"issue":"6","key":"10.1016\/j.earlhumdev.2011.12.012_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2011.07.003","article-title":"Neonatal outcome of pregnancies complicated by hypertensive disorders between 34 and 37weeks of gestation: a 7year retrospective analysis of a national registry","volume":"205","author":"Langenveld","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"1\u20132","key":"10.1016\/j.earlhumdev.2011.12.012_bb0165","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejogrb.2006.02.015","article-title":"Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial","volume":"128","author":"Vigil-De Gracia","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"10.1016\/j.earlhumdev.2011.12.012_bb0020","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJM199607253350407","article-title":"Treatment of hypertension in pregnant women","volume":"335","author":"Sibai","year":"1996","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.earlhumdev.2011.12.012_bb0170","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1067\/mob.2000.107928","article-title":"Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy","volume":"183","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.earlhumdev.2011.12.012_bb0175","first-page":"CD001449","article-title":"Drugs for treatment of very high blood pressure during pregnancy","volume":"3","author":"Duley","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"1 Suppl.","key":"10.1016\/j.earlhumdev.2011.12.012_bb0035","doi-asserted-by":"crossref","first-page":"127S","DOI":"10.1111\/j.1365-2125.1982.tb01901.x","article-title":"The evaluation of labetalol in the treatment of hypertension complicating pregnancy","volume":"13","author":"Michael","year":"1982","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.earlhumdev.2011.12.012_bb0180","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1471-0528.1986.tb07950.x","article-title":"The effect of maternal labetalol on the newborn infant","volume":"93","author":"Macpherson","year":"1986","journal-title":"Br J Obstet Gynaecol"},{"issue":"10","key":"10.1016\/j.earlhumdev.2011.12.012_bb0045","first-page":"467","article-title":"Metabolic and cardiovascular effects of beta-blockers taken by the mother in newborn infants","volume":"17","author":"Brosset","year":"1988","journal-title":"Presse Med"},{"issue":"6","key":"10.1016\/j.earlhumdev.2011.12.012_bb0050","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1651-2227.1989.tb11183.x","article-title":"Severe adverse effects of maternal labetalol in a preterm infant","volume":"78","author":"Haraldsson","year":"1989","journal-title":"Acta Paediatr Scand"},{"issue":"2","key":"10.1016\/j.earlhumdev.2011.12.012_bb0055","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1055\/s-2007-994563","article-title":"Neonatal adrenergic blockade following single dose maternal labetalol administration","volume":"11","author":"Klarr","year":"1994","journal-title":"Am J Perinatol"},{"issue":"3","key":"10.1016\/j.earlhumdev.2011.12.012_bb0060","first-page":"146","article-title":"Cardiac arrest in newborn of mother treated with labetalol","volume":"40","author":"Sala","year":"1993","journal-title":"Rev Esp Anestesiol Reanim"},{"issue":"1","key":"10.1016\/j.earlhumdev.2011.12.012_bb0065","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0022-3476(95)70277-6","article-title":"Use of glucagon to treat neonatal low-output congestive heart failure after maternal labetalol therapy","volume":"127","author":"Stevens","year":"1995","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.earlhumdev.2011.12.012_bb0070","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/00016349209007974","article-title":"Fetal death following labetalol administration in pre-eclampsia","volume":"71","author":"Olsen","year":"1992","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"10.1016\/j.earlhumdev.2011.12.012_bb0075","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/sj.jp.7211193","article-title":"A randomized-controlled trial of prophylactic hydrocortisone supplementation for the prevention of hypotension in extremely low birth weight infants","volume":"25","author":"Efird","year":"2005","journal-title":"J Perinatol"},{"issue":"2","key":"10.1016\/j.earlhumdev.2011.12.012_bb0080","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1055\/s-2007-994649","article-title":"The frequency of hypoglycemia in full-term large and small for gestational age newborns","volume":"10","author":"Holtrop","year":"1993","journal-title":"Am J Perinatol"},{"issue":"9","key":"10.1016\/j.earlhumdev.2011.12.012_bb0085","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1471-0528.1983.tb09333.x","article-title":"Side effects of labetalol in newborn infants","volume":"90","author":"Woods","year":"1983","journal-title":"Br J Obstet Gynaecol"},{"issue":"2","key":"10.1016\/j.earlhumdev.2011.12.012_bb0090","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0028-2243(93)90022-5","article-title":"Effect of labetalol infusion on uterine and fetal hemodynamics and fetal cardiac function","volume":"51","author":"Jouppila","year":"1993","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"10.1016\/j.earlhumdev.2011.12.012_bb0095","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.arcped.2005.01.024","article-title":"Neonatal outcome after exposure to beta adrenergic blockers late in pregnancy","volume":"12","author":"Cissoko","year":"2005","journal-title":"Arch Pediatr"},{"issue":"5","key":"10.1016\/j.earlhumdev.2011.12.012_bb0185","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/sj.jp.7210563","article-title":"Variations in prevalence of hypotension, hypertension, and vasopressor use in NICUs","volume":"21","author":"Al Aweel","year":"2001","journal-title":"J Perinatol"},{"issue":"6","key":"10.1016\/j.earlhumdev.2011.12.012_bb0110","doi-asserted-by":"crossref","first-page":"F450","DOI":"10.1136\/fn.88.6.F450","article-title":"Hypotension in the very low birthweight infant: the old, the new, and the uncertain","volume":"88","author":"Dasgupta","year":"2003","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"2","key":"10.1016\/j.earlhumdev.2011.12.012_bb0115","first-page":"147","article-title":"Blood pressure values in 500- to 750-gram birthweight infants in the first week of life","volume":"11","author":"Spinazzola","year":"1991","journal-title":"J Perinatol"},{"issue":"6917","key":"10.1016\/j.earlhumdev.2011.12.012_bb0120","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1136\/bmj.307.6917.1451","article-title":"Relation between birth weight and blood pressure: longitudinal study of infants and children","volume":"307","author":"Launer","year":"1993","journal-title":"BMJ"},{"issue":"8 Pt 1","key":"10.1016\/j.earlhumdev.2011.12.012_bb0125","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/sj.jp.7200228","article-title":"Fetal influences on neonatal blood pressure","volume":"19","author":"Alves","year":"1999","journal-title":"J Perinatol"},{"issue":"3","key":"10.1016\/j.earlhumdev.2011.12.012_bb0130","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1542\/peds.71.3.364","article-title":"Evaluation of the preterm infant for patent ductus arteriosus","volume":"71","author":"Ellison","year":"1983","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.earlhumdev.2011.12.012_bb0135","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/j.1875-9114.1983.tb03252.x","article-title":"Labetalol: a review of its pharmacology, pharmacokinetics, clinical uses and adverse effects","volume":"3","author":"MacCarthy","year":"1983","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.earlhumdev.2011.12.012_bb0140","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/0002-9378(90)90386-L","article-title":"Labetalol pharmacokinetics in pregnancy-induced hypertension","volume":"162","author":"Rogers","year":"1990","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.earlhumdev.2011.12.012_bb0145","doi-asserted-by":"crossref","first-page":"F150","DOI":"10.1136\/fn.79.2.F150","article-title":"Adverse neonatal effects of maternal labetalol treatment","volume":"79","author":"Crooks","year":"1998","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"12","key":"10.1016\/j.earlhumdev.2011.12.012_bb0150","first-page":"1507","article-title":"Effects of maternal labetalol on the newborn infant","volume":"29","author":"Munshi","year":"1992","journal-title":"Indian Pediatr"},{"issue":"1","key":"10.1016\/j.earlhumdev.2011.12.012_bb0190","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1471-0528.1989.tb01574.x","article-title":"The fetal outcome in a randomized double-blind controlled trial of labetalol versus placebo in pregnancy-induced hypertension","volume":"96","author":"Pickles","year":"1989","journal-title":"Br J Obstet Gynaecol"}],"container-title":["Early Human Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378378211003823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378378211003823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T17:51:34Z","timestamp":1642096294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378378211003823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0378378211003823"],"URL":"https:\/\/doi.org\/10.1016\/j.earlhumdev.2011.12.012","relation":{},"ISSN":["0378-3782"],"issn-type":[{"value":"0378-3782","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}